FLGT Q4 2019 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$447M

Q4 2019 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$8M+47.7% YoY

Gross Profit

$5M56.7% margin

Operating Income

-$409,000-4.9% margin

Net Income

-$296,000-3.5% margin

EPS (Diluted)

$-0.01

QoQ Revenue Growth

-18.9%

Cash Flow

Operating Cash Flow

-$116,000

Free Cash Flow

-$714,000

Stock-Based Comp.

$938,000

Balance Sheet

Total Assets

$89M

Total Liabilities

$6M

Stockholders' Equity

$83M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$6M	+47.7%
Gross Profit	$5M	$3M	+63.1%
Operating Income	-$409,000	-$1M	+60.3%
Net Income	-$296,000	-$935,000	+68.3%

Geographic Segments

UNITED STATES

$6M74%

Other Countries

$2M18%

CANADA

$643,0008%